logo-loader
PRIVATE-UK:ARECO

Arecor

Receive alerts
Market:
PRIVATE-UK
Market Cap:
£0.00
Price
£0.00
Change
0%
52 weeks high
0
52 weeks low
0

Filter by article type

Viewing results 1-7 of 7

Health

Arecor doses first patient in Phase I trial of AT247 diabetes treatment

The firm said the double-blind, three-way cross over study in Austria will compare the results of AT247 against current insulin treatments for people living with Type 1 diabetes...

on 05/07/2019
Health

Arecor given green light to begin Phase I trial of AT247 diabetes treatment

The study will compare the AT247’s pharmacokinetic and pharmacodynamic profiles with two current best in class products - Novo Nordisk’s Novolog and Fiasp...

on 03/20/2019
Health

Arecor appoints ex-IXICO CFO Susan Lowther as its new finance chief

Lowther’s first foray into the pharma and biotech sector was with US giant Monsanto, after which she has gone on to work for smaller industry players such as Novacyt, BioWisdom and, more recently, IXICO...

on 03/11/2019
Health

Arecor steps into pharma limelight with diabetes treatment

A clinical trial of one of the Unilever spin-out's own drugs gets underway this quarter...

on 01/29/2019